Predict your next investment

Corporation
HEALTHCARE | Drug Development
junshipharma.com

See what CB Insights has to offer

Stage

IPO - III

Investors Count

1

Deal Terms

1

Portfolio Exits

1

Investments

10

Shanghai Junshi Biosciences Funding, Shanghai Junshi Biosciences Valuation & Shanghai Junshi Biosciences Revenue

4 Fundings

Shanghai Junshi Biosciences's latest funding round was a IPO - III for $716.53M on July 15, 2020.

Shanghai Junshi Biosciences's latest post-money valuation is from July 2020.

Sign up for a free 30-day trial to see Shanghai Junshi Biosciences's valuations in July 2020 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

7/15/2020

IPO - III

$716.53M

$99M

$0.00B

((9.99x))

FY 1234

1

4/8/2020

Take Private

$99M

$0.00B

((9.99x))

FY 1234

10

12/24/2018

IPO - II

$99M

$0.00B

((9.99x))

FY 1234

10

8/13/2015

IPO

$99M

$0.00B

((9.99x))

FY 1234

10

Date

7/15/2020

4/8/2020

12/24/2018

8/13/2015

Round

IPO - III

Take Private

IPO - II

IPO

Amount

$716.53M

$99M

$99M

$99M

Investors

Valuation

$99M

Revenue

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

Sources

1

10

10

10

Shanghai Junshi Biosciences Deal Terms

1 Deal Term

Shanghai Junshi Biosciences's deal structure is available for 1 funding round, including their IPO - III from July 15, 2020.

Round

IPO - III

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

IPO - III

Shanghai Junshi Biosciences Investors

1 Investors

Shanghai Junshi Biosciences has 1 investors. Shanghai Junshi Biosciences invested in Shanghai Junshi Biosciences's Take Private funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

4/8/2020

4/8/2020

1
Take Private

Corporation

China

First funding

4/8/2020

Last Funding

4/8/2020

Investor

Rounds

1
Take Private

Board Seats

Type

Corporation

Location

China

Shanghai Junshi Biosciences Acquisitions

1 Acquisition

Shanghai Junshi Biosciences acquired 1 company. Their latest acquisition was Shanghai Junshi Biosciences on April 08, 2020.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

4/8/2020

Take Private

Take Private

1

Date

4/8/2020

Investment Stage

Take Private

Companies

Valuation

Total Funding

Note

Take Private

Sources

1

Shanghai Junshi Biosciences Investments

10 Investments

Shanghai Junshi Biosciences has made 10 investments. Their latest investment was in GRIT Biotechnology as part of their Series A - II on July 7, 2021.

CBI Logo

Shanghai Junshi Biosciences Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

7/15/2021

Series A - II

GRIT Biotechnology

Yes

4

5/11/2021

Series A

Immunophage

$31.11M

Yes

6

2/9/2021

Series A

Zhishan Weixin

Yes

7

2/5/2021

Unattributed

Subscribe to see more

$99M

Subscribe to see more

10

2/2/2021

Corporate Minority - P2P

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/15/2021

5/11/2021

2/9/2021

2/5/2021

2/2/2021

Round

Series A - II

Series A

Series A

Unattributed

Corporate Minority - P2P

Company

GRIT Biotechnology

Immunophage

Zhishan Weixin

Subscribe to see more

Subscribe to see more

Amount

$31.11M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

4

6

7

10

10

Shanghai Junshi Biosciences Portfolio Exits

1 Portfolio Exit

Shanghai Junshi Biosciences has 1 portfolio exit. Their latest portfolio exit was Shanghai Junshi Biosciences on July 15, 2020.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

7/15/2020

IPO - III

$991

1

Date

7/15/2020

Exit

IPO - III

Companies

Valuation

$991

Acquirer

Sources

1

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.